Načítá se...
Osteoporosis management in hematologic stem cell transplant recipients: Executive summary
BACKGROUND: Treatment advances have reduced the adverse events associated with hematopoietic stem cell transplant (HSCT) and led to an increased number of transplants performed. HSCT patients are living longer with concerns on long-term outcomes. Bone fragility and fracture are at the forefront for...
Uloženo v:
| Vydáno v: | J Bone Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095179/ https://ncbi.nlm.nih.gov/pubmed/33996429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100361 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|